Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-40
Closed -$2K 1099
2022
Q3
$2K Buy
40
+5
+14% +$255 ﹤0.01% 931
2022
Q2
$1K Hold
35
﹤0.01% 1007
2022
Q1
$2K Buy
35
+5
+17% +$270 ﹤0.01% 916
2021
Q4
$2K Buy
30
+6
+25% +$473 ﹤0.01% 988
2021
Q3
$2K Hold
24
﹤0.01% 899
2021
Q2
$3K Hold
24
﹤0.01% 810
2021
Q1
$1K Buy
+24
New +$1.73K ﹤0.01% 826

Other funds holding AGEN

Salem Investment Counselors's AGEN Position: Q4 2022 in Review

Salem Investment Counselors sold out of Agenus (AGEN) in Q4 2022, closing a stake of 40 shares — an estimated $2K sold.

Salem Investment Counselors first reported a position in AGEN in Q1 2021 and held it in 7 quarters. The position peaked at $3K in Q2 2021. 155 funds tracked by Wall St. Rank hold AGEN as of Q4 2022.

  • Salem Investment Counselors reported no remaining Agenus position as of Q4 2022 after selling out during the quarter.
  • Salem Investment Counselors sold 40 Agenus shares in Q4 2022, an estimated $2K.
  • Salem Investment Counselors first reported a position in Agenus in Q1 2021 and held it in 7 quarters.
  • Salem Investment Counselors's Agenus position peaked at $3K in Q2 2021.
  • 155 funds tracked by Wall St. Rank held Agenus as of Q4 2022.

Based on Salem Investment Counselors's 13F filing for Q4 2022, filed 15 Feb 2023.